Better Health for All

LeMaitre Vascular's core business involves developing and marketing medical devices and implants used in vascular surgery, which directly contributes to treating vascular diseases and improving patient outcomes, aligning with the 'Better Health for All' value

. The company provides surgeon training, indicating an investment in proper usage and potentially better patient outcomes . The company received Artegraft MDR CE Mark Approval in April 2025 . However, there is no specific information available regarding price accessibility, vulnerable population reach, or health equity programs. The clinical trial registration provides no additional data . The company's focus is primarily on treatment rather than prevention, limiting its impact on broad healthcare access. Based on the available information, a score of +10 is appropriate, reflecting the positive health impact of the company's products with consideration for the limited scope of impact on broader healthcare accessibility. The company's training programs also support this score .

Fair Trade & Ethical Sourcing

LeMaitre Vascular's Supplier Code of Conduct, revised March 2024, states that all suppliers are required to adhere to its standards.

However, there is no evidence that 100% of supplier contracts include enforceable ethical-sourcing clauses, leading to a score of -100. The company has a Conflict Minerals Disclosure and requires suppliers to procure tantalum, tin, tungsten, gold, and rare earth minerals from sources that do not finance armed groups in conflict-affected areas, indicating some high-risk spend but also mitigation efforts. The company had one Class II recall in Europe and one Class 3 recall in the U.S. in 2023, neither involving patient injury. Corrective action plans (CAPAs) related to FDA observations showed closure times of 81, 120, 121, and 216 days. The median closure time is 120.5 days, which falls into the -60 tier.

No War, No Weapons

LeMaitre Vascular, Inc. determined that a limited number of its products contain conflict minerals, specifically in isolated components of radiopaque tape, certain catheters, illuminators, resectors, and powered phlebectomy devices.

For the 2020 reporting period, the company contacted three suppliers, and for the 2024 reporting period, it contacted five suppliers, requesting representations or reports regarding the source of these conflict minerals. The company relies on supplier responses and policies for information about conflict minerals. One supplier indicated that smelters in their supply chain sourcing conflict minerals from the Democratic Republic of the Congo or an adjoining country have been validated by an independent, third-party assessment. Another supplier indicated they are not aware of using metals derived from the Conflict Region in their products. One supplier confirmed that no conflict minerals originated from the Democratic Republic of the Congo or an adjoining country, or from suppliers sourcing in that region unless certified as “conflict free.” The company's Code of Business Conduct and Ethics, revised in October 2024, outlines general board oversight responsibilities for administering the Code, but does not specifically mention oversight of defense-related business activities. The company is a medical device company and no evidence suggests involvement in defense business.

Planet-Friendly Business

LMAT.US has no publicly available carbon emissions data, nor any documented climate reduction targets or pledges.

The company is not participating in any tracked reduction initiatives. There is no information provided regarding environmental compliance violations, certifications, awards, or recognitions. Significant data gaps exist across all environmental performance metrics, including renewable energy use, water use, green building certifications, waste diversion, EU Taxonomy alignment, lifecycle impact analysis, recycled material ratios, carbon offset quality, climate-positive initiatives, supply chain climate transparency, supplier SBTi targets, biodiversity efforts, deforestation policies, environmental impact assessments, net-zero targets, TCFD alignment, climate scenario analysis, stranded assets transparency, water from stressed basins, packaging CO2 reduction, climate justice initiatives, and just transition programs.